openPR Logo
Press release

COVID-19: Potential Impact on Anticoagulants Market Size to Grow $43.42 billion by 2025, at CAGR of 7.5% With Top Companies Aspen Holdings, Bayer AG

08-05-2020 04:02 PM CET | Health & Medicine

Press release from: Allied Market Research

Anticoagulants Market

Anticoagulants Market

UPDATE AVAILABLE ON-DEMAND

The Anticoagulants Market was valued at $24,265 million in 2017, and is expected to reach $43,427 million by 2025, growing at a CAGR of 7.5% from 2018 to 2025.

Global Anticoagulants Market Report provides an overview of the market based on key parameters such as market size, sales, sales analysis and key drivers. The market size of the market is expected to grow on a large scale during the forecast period (2019-2026). This report covers the impact of the latest COVID-19 on the market. The coronavirus epidemic (COVID-19) has affected all aspects of life around the world. This has changed some of the market situation. The main purpose of the research report is to provide users with a broad view of the market. Initial and future assessments of rapidly changing market scenarios and their impact are covered in the report.

Click Here To Access Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/1673

Anticoagulants are medicinal substances that reduce the coagulation of blood and prolong the clotting time. Anticoagulant drugs achieve their effects by suppressing the synthesis or function of various clotting factors that exist in the blood. The global anticoagulants market is anticipated to show significant market growth during the forecast period, owing to increase in prevalence of ischemic heart disease and venous thromboembolism (VTE) and awareness of novel oral anticoagulants (NOACs). In addition, increasing number of geriatric population and growing incidence of obese population is expected to further increase the demand for anticoagulants throughout the forecast period. On the other side, very high cost of NOACs is expected to negatively affect the growth of the anticoagulants market.

On the basis of drug class, the anticoagulants market is segmented as NOACs, heparin & LMWH, vitamin K antagonist, and others. At present, the NOACs segment is a major revenue-generating segment and is anticipated to show dominance during the forecast period, owing to growing awareness of NOACs and rising use of NOACs over the warfarin. However, higher price of NOACs hinders the market growth. As per the route of administration, the anticoagulants market is segmented as oral anticoagulant and injectable anticoagulant. At present, the oral anticoagulant segment is a major revenue-generating segment and is anticipated to show dominance during the forecast period, owing to growing adoption of NOACs and rising availability of lower cost warfarin.

The application market is categorized as atrial fibrillation & heart attack, stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), and others. Presently, the atrial fibrillation & heart attack segment is a major revenue contributor and is anticipated to show dominance throughout the forecast period, owing to large target population and increase in use of anticoagulants to treat these conditions. However, the DVT segment is expected to show the fastest market growth, attributed to the increase in prevalence of DVT and technological advancement in diagnosis of DVT.

North America accounted approximately one-half of the global market share in 2017 and is expected to remain dominant throughout the forecast period. This was attributed to the higher demand for novel therapeutics, strong presence of key players, early diagnosis, developed healthcare infrastructure, presence of trained medical professionals, and larger target population. However, the Asia-Pacific region is expected to experience the highest growth rate during the forecast period, majorly owing to improving healthcare infrastructure with developing economies, rising diagnosis rate, enhancing health awareness, and increasing prevalence of cardiovascular disease and VTE.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/1673

The Major Key Players Are:

• Aspen Holdings
• Bayer AG
• Boehringer Ingelheim GmbH
• Bristol-Myers Squibb Company
• Daiichi Sankyo Company, Limited
• GlaxoSmithKline plc.
• Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
• Pfizer, Inc.
• Portola Pharmaceuticals, Inc.
• Sanofi S.A.

Key Findings of the Anticoagulants Market:

• As per the drug class, the NOACs segment is expected to show the fastest market growth and grow at a CAGR of 8.0% from 2018 to 2025.
• On the basis of the route of administration, the oral anticoagulant segment held more than half of the global market share in 2017 and is expected to remain dominant throughout the forecast period.
• By application, the deep vein thrombosis (DVT) segment is expected to exhibit the fastest growth at a CAGR of 8.4% from 2018 to 2025.
• Region-wise, the Asia-Pacific region is expected to experience growth at the highest rate, registering a CAGR of 9.2% during the forecast period.

Contact:

David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release COVID-19: Potential Impact on Anticoagulants Market Size to Grow $43.42 billion by 2025, at CAGR of 7.5% With Top Companies Aspen Holdings, Bayer AG here

News-ID: 2104379 • Views:

More Releases from Allied Market Research

Driving Innovation : Automotive Hypervisor Market to Hit $2.04 Billion by 2030, Fueled by a 31.9% CAGR
Driving Innovation : Automotive Hypervisor Market to Hit $2.04 Billion by 2030, …
According to a recent report published by Allied Market Research, titled, "Automotive Hypervisor Market by Vehicle Type, Type, Level of Automation and Vehicle Class: Global Opportunity Analysis and Industry Forecast, 2021-2030," 𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐚𝐮𝐭𝐨𝐦𝐨𝐭𝐢𝐯𝐞 𝐡𝐲𝐩𝐞𝐫𝐯𝐢𝐬𝐨𝐫 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 $𝟏𝟑𝟏.𝟐𝟎 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟎, 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $𝟐,𝟎𝟑𝟕.𝟔𝟎 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟎, 𝐫𝐞𝐠𝐢𝐬𝐭𝐞𝐫𝐢𝐧𝐠 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟑𝟏.𝟗% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟏 𝐭𝐨 𝟐𝟎𝟑𝟎. North America dominates the market in terms of revenue, followed
Driving Off the Beaten Path : Utility Terrain Vehicle Market to Reach $1.8 Billion by 2032, With a 5.5% CAGR
Driving Off the Beaten Path : Utility Terrain Vehicle Market to Reach $1.8 Billi …
According to the report published by Allied Market Research, 𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐮𝐭𝐢𝐥𝐢𝐭𝐲 𝐭𝐞𝐫𝐫𝐚𝐢𝐧 𝐯𝐞𝐡𝐢𝐜𝐥𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 $𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟐, 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $𝟏.𝟖 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟓.𝟓% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟑 𝐭𝐨 𝟐𝟎𝟑𝟐. 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰 A utility terrain vehicle (UTVs), also known as a utility task vehicle or side-by-side (SxS), is a specialized off-road vehicle designed for several utility and recreational purposes. UTVs
Speaking Up : Automotive Voice Recognition System Market Set to Reach $14.7 Billion by 2032, Fueled by a 16.1% CAGR
Speaking Up : Automotive Voice Recognition System Market Set to Reach $14.7 Bill …
According to a new report published by Allied Market Research, titled, "Automotive Voice Recognition System Market," 𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐚𝐮𝐭𝐨𝐦𝐨𝐭𝐢𝐯𝐞 𝐯𝐨𝐢𝐜𝐞 𝐫𝐞𝐜𝐨𝐠𝐧𝐢𝐭𝐢𝐨𝐧 𝐬𝐲𝐬𝐭𝐞𝐦 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 $𝟑.𝟒 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟐, 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $𝟏𝟒.𝟕 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟏𝟔.𝟏% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟑 𝐭𝐨 𝟐𝟎𝟑𝟐. 𝐅𝐮𝐭𝐮𝐫𝐢𝐬𝐭𝐢𝐜 𝐓𝐫𝐞𝐧𝐝𝐬 𝐚𝐧𝐝 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬 Key trends impacting the automotive voice recognition system market: > 𝐄𝐧𝐡𝐚𝐧𝐜𝐞𝐝 𝐔𝐬𝐞𝐫 𝐄𝐧𝐠𝐚𝐠𝐞𝐦𝐞𝐧𝐭 - The automotive industry prioritizes user satisfaction,
Electric Truck Market to Reach $3.86 Billion by 2030 with a 26.4% CAGR - Industry Report
Electric Truck Market to Reach $3.86 Billion by 2030 with a 26.4% CAGR - Industr …
Allied Market Research (AMR) has recently published a comprehensive report entitled "Electric Truck Market." According to a research report, 𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐞𝐥𝐞𝐜𝐭𝐫𝐢𝐜 𝐭𝐫𝐮𝐜𝐤 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 $𝟑𝟗𝟐.𝟑 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟎, 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $𝟑,𝟖𝟔𝟏.𝟖 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟎, 𝐫𝐞𝐠𝐢𝐬𝐭𝐞𝐫𝐢𝐧𝐠 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟐𝟔.𝟒% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟏 𝐭𝐨 𝟐𝟎𝟑𝟎. This research report provides a qualitative and quantitative analysis of recent technological developments, market dynamics, segmental analysis, regional analysis, key investment

All 5 Releases


More Releases for Anticoagulant

Anticoagulant Treatment Market 2021 | Detailed Report
The Anticoagulant Treatment market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The Anticoagulant Treatment report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4988667 The Anticoagulant Treatment research report also provides
Anticoagulant Reversal Medicine Market global outlook and forecast 2021 -2027
The Global Anticoagulant Reversal Medicine Market research report is a careful examination of the worldwide industry which has been a region of enthusiasm for a Anticoagulant Reversal Medicine makers, organizations, authorities, chiefs, and likely speculators, and analysts. The report profoundly lights up noteworthy features in the business, including a contention situation, condition, portions, showcase size, share, gainfulness, development potential, and advancements. The report likewise
Anticoagulants Market To See Record Break Revenue $43.42 Million By 2025 | Vitam …
Anticoagulants are medicinal substances that reduce the coagulation of blood and prolong the clotting time. Anticoagulant drugs achieve their effects by suppressing the synthesis or function of various clotting factors that exist in the blood. The global anticoagulants market is anticipated to show significant market growth during the forecast period, owing to increase in prevalence of ischemic heart disease and venous thromboembolism (VTE) and awareness of novel oral anticoagulants (NOACs).
Anticoagulant Drugs Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Anticoagulant Drugs market. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/241687/global-anticoagulant-drugs-market Global Anticoagulant Drugs Market: Forecast by Type / Application / Region Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time. According to this study, over the next five years the Anticoagulant Drugs
Global Antithrombotic/Anticoagulant Drugs Technologies and Market Research Repor …
Researchmoz added Most up-to-date research on "Antithrombotic/Anticoagulant Drugs: Technologies and Global Markets" to its huge collection of research reports. The global market for antithrombotic/anticoagulant drugs should reach $27.3 billion by 2021 from $18.9 billion in 2016, a compound annual growth rate (CAGR) of 7.6%, from 2016 to 2021. The North American antithrombotic/anticoagulant drugs market is expected to grow from nearly $8.0 billion in 2016 to nearly $11.0 billion in 2021, a CAGR
Global Heparin Anticoagulant Market $11.5 Billion by 2021
The global heparin anticoagulant market is estimated to reach $11.5 Billion in 2021, growing at a CAGR of 4.4% from 2017 to 2021, according to a market research report Heparin Anticoagulant Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc. The global heparin anticoagulant market report provides market size (Revenue $Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021). The global heparin anticoagulant market